- Aghbali A., Abbasabadi F.M., Delazar A., Hosseini S. V., Shahneh F.Z., Baradaran B., Janani M. 2014. Induction of apoptosis and cytotoxic activities of Iranian orthodox black tea extract (BTE) using in vitro models. Advanced Pharmaceutical Bulletin, 4:255.
- Bradley B.F., Brown S.L., Chu S., Lea R.W. 2009. Effects of orally administered lavender essential oil on responses to anxiety‐provoking film clips. Human Psychopharmacology: Clinical and Experimental, 24:319-330.
- Carvalho-Freitas M.I.R., Costa M. 2002. Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. Biological and Pharmaceutical Bulletin, 25: 1629-1633.
- Cavadas C., Araujo I., Cotrim M.D., Amaral T., Cunha A. P., Macedo T., Ribeiro C.F. 1995. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittel-Forschung, 45:753-755.
- Chen B., Zhou H., Zhao W., Zhou W., Yuan Q., Yang G. 2012. Effects of aqueous extract of Portulaca oleracea L. on oxidative stress and liver, spleen leptin, PARα and FAS mRNA expression in high-fat diet induced mice. Molecular Biology Reports, 39:7981-7988.
- Clément Y., Calatayud F., Belzung C. 2002. Genetic basis of anxiety-like behaviour: a critical review. Brain Research Bulletin, 57:57-71.
- Clement Y., Chapouthier G. 1998. Biological bases of anxiety. Neuroscience & Biobehavioral Reviews, 22:623-633.
- Clément Y., Joubert C., Kopp C., Lepicard E. M., Venault P., Misslin R., Cadot M., Chapouthier G. 2007. Anxiety in mice: a principal component analysis study. Neural Plasticity, 2007:35457.
- Cooper S. F., Drolet D., Dugal R. 1984. Comparative bioavailability of two oral formulations of flurazepam in human subjects. Biopharmaceutics and Drug Disposition, 5(2):127-139.
- Finn D.A., Rutledge-Gorman M.T., Crabbe J. C. 2003. Genetic animal models of anxiety. Neurogenetics, 4: 109-135.
- Greenblatt D.J., Shader R.I., Franke K., Maclaughlin D.S., Ransil B.J., Weser J.K. 1977. Kinetics of intravenous chlordiazepoxide: sex differences in drug distribution. Clinical Pharmacology & Therapeutics, 22(6):893-903.
- Hadjikhani R. 2009. Anxiolytic-like effects of dichloromethane extracts of valerian (DEV) in adult male wistar rats. International Journal of Medical and Health Sciences, 3(7):157-161.
- Houghton P.J. 1988. The biological activity of valerian and related plants. Journal of Ethnopharmacology, 22:121-142.
- Houghton P.J. 1999. The scientific basis for the reputed activity of Valerian. Journal of Pharmacy and Pharmacology, 51:505-512.
- Jafari K., Gharibzadeh S., Faghihi M., Karimian S. M., Hamzehloo M. and Keshavarz M. 2006. Effect of iranian black tea extract and its isolated thearubigins on intestinal transit time in mice. Journal of Kerman University of Medical Sciences, 13: 37-42.
- Leathwood P., Chauffard F. 1985. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Medica, 51(02): 144-148.
- Miladi-Gorgi H., Vafaei A. A., Rashidy-Pour A., Taherian A.A., Jarrahi M., Emami-Abargoie M. 2010. Investigation of anxiolytic effects of the aqueous extract of Portulaca oleracea in mice. Iranian Journal of Pharmaceutical Research: 57.
- Miladi G.H., Rashidipour A., Fath E. Y., Vafaei A.A., Taherian A.A. 2008. The role of morphine dependence on the level of anxiety in rat. Journal of Gorgan University of Medical Sciences, 10(2):5-10.
- Najafzadeh M., Amini K., Faghihzadeh S., Monsef E.H. 2016. Effect of valerian on anxiety of nurses working in the ICUs: a randomized controlled trial. Preventive Care in Nursing and Midwifery Journal, 5(2):1-12
- Pellow S., Chopin P., File S.E., Briley M. 1985. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14:149-167.
- Pellow S. and File S. E. 1986. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacology Biochemistry and Behavior, 24:525-529.
- Popoli M., Yan Z., McEwen B.S., Sanacora G. 2012. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nature Reviews Neuroscience, 13:22-37.
- Rector N.A. 2005. Anxiety disorders an information guide. Centre for Addiction and Mental Health, 46 pages.
- Rodgers R.J., Johnson N.J.T. 1995. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacology Biochemistry and Behavior, 52:297-303.
- Roser M., Ritchie H., Ortiz-Ospina E. 2015. Internet. Our World in Data. Retrieved July 30:2021.
- Shastry R., Ullal S.D., Karkala S., Rai S., Gadgade A. 2016. Anxiolytic activity of aqueous extract of Camellia sinensis in rats. Indian Journal of Pharmacology, 48: 681.
- Tsuda M., Suzuki T., Misawa M., Nagase H. 1996. Involvement of the opioid system in the anxiolytic effect of diazepam in mice. European Journal of Pharmacology 307:7-14.
- Varty G.B., Cohen-Williams M.E., Morgan C.A., Pylak U., Duffy R.A., Lachowicz J.E., Carey G.J., Coffin V.L. 2002. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology, 27:371-379.
- Yousefi M. 2016. Comparison of Anxiolytic-like effects of Echium amoenum in the male and female rats. Der Pharma Chemica, 8(18):35-39.
- Yuen E.Y., Liu W., Karatsoreos I.N., Feng J., McEwen B.S., Yan Z. 2009. Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proceedings of the National Academy of Sciences, 106: 14075-14079.
- Zhang Z., Schulteis G. 2008. Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze. Pharmacology Biochemistry and Behavior, 89:392-403.
|
